SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

ENDRA Life Sciences Inc. – ‘10-K’ for 12/31/22 – ‘EXCEL’

On:  Thursday, 3/16/23, at 4:51pm ET   ·   For:  12/31/22   ·   Accession #:  1654954-23-3044   ·   File #:  1-37969

Previous ‘10-K’:  ‘10-K’ on 3/30/22 for 12/31/21   ·   Next & Latest:  ‘10-K’ on 3/28/24 for 12/31/23   ·   26 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/16/23  ENDRA Life Sciences Inc.          10-K       12/31/22   60:4.2M                                   Blueprint/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    859K 
 2: EX-10.6     Non-Employee Director Compensation Policy           HTML     20K 
 3: EX-21.1     Subsidiaries of the Company                         HTML     16K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML     16K 
 5: EX-23.2     Consent of Expert or Counsel                        HTML     16K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     21K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     21K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     18K 
14: R1          Cover                                               HTML     86K 
15: R2          Consolidated Balance Sheets                         HTML    111K 
16: R3          Consolidated Balance Sheets (Parenthetical)         HTML     38K 
17: R4          Consolidated Statements of Operations               HTML     75K 
18: R5          Consolidated Statements of Stockholders Equity      HTML     66K 
19: R6          Consolidated Statements of Cash Flows               HTML     92K 
20: R7          Nature of the Business                              HTML     20K 
21: R8          Summary of Significant Accounting Policies          HTML     48K 
22: R9          Inventory                                           HTML     19K 
23: R10         Fixed Assets                                        HTML     25K 
24: R11         Accounts Payable and Accrued Liabilities            HTML     26K 
25: R12         Bank Loans                                          HTML     21K 
26: R13         Capital Stock                                       HTML     33K 
27: R14         Common Stock Options and Restricted Stock Units     HTML     32K 
                (RSUs)                                                           
28: R15         Common Stock Warrants                               HTML     31K 
29: R16         Commitments and Contingencies                       HTML     34K 
30: R17         Income Taxes                                        HTML     38K 
31: R18         Subsequent Events                                   HTML     19K 
32: R19         Summary of Significant Accounting Policies          HTML     78K 
                (Policies)                                                       
33: R20         Summary of Significant Accounting Policies          HTML     25K 
                (Tables)                                                         
34: R21         Fixed Assets (Tables)                               HTML     24K 
35: R22         Accounts Payable and Accrued Liabilities (Tables)   HTML     26K 
36: R23         Common Stock Options and Restricted Stock Units     HTML     32K 
                (RSUs)(Tables)                                                   
37: R24         Common Stock Warrants (Tables)                      HTML     31K 
38: R25         Commitments and Contingencies (Tables)              HTML     24K 
39: R26         Income Taxes (Tables)                               HTML     33K 
40: R27         Summary of Significant Accounting Policies          HTML     23K 
                (Details)                                                        
41: R28         Summary of Significant Accounting Policies          HTML     32K 
                (Details Narrative)                                              
42: R29         Inventory (Details Narrative)                       HTML     19K 
43: R30         Fixed Assets (Details)                              HTML     26K 
44: R31         Fixed Assets (Details Narrative)                    HTML     19K 
45: R32         Accounts Payable and Accrued Liabilities (Details)  HTML     32K 
46: R33         Bank Loans (Details Narrative)                      HTML     25K 
47: R34         Capital Stock (Details Narrative)                   HTML     75K 
48: R35         Common Stock Options and Restricted Stock Units     HTML     52K 
                (RSUs) (Details)                                                 
49: R36         Common Stock Options and Restricted Stock Units     HTML     31K 
                (RSUs) (Details Narrative)                                       
50: R37         Common Stock Warrants (Details)                     HTML     42K 
51: R38         Commitments and Contingencies (Details)             HTML     33K 
52: R39         Commitments and Contingencies (Details Narrative)   HTML     51K 
53: R40         Income Taxes (Details)                              HTML     28K 
54: R41         Income Taxes (Details 1)                            HTML     29K 
55: R42         Income Taxes (Details narrative)                    HTML     20K 
58: XML         IDEA XML File -- Filing Summary                      XML    102K 
56: XML         XBRL Instance -- ndra_10k_htm                        XML    623K 
57: EXCEL       IDEA Workbook of Financial Reports                  XLSX     63K 
11: EX-101.CAL  XBRL Calculations -- ndra-20221231_cal               XML    106K 
13: EX-101.DEF  XBRL Definitions -- ndra-20221231_def                XML    259K 
10: EX-101.LAB  XBRL Labels -- ndra-20221231_lab                     XML    636K 
12: EX-101.PRE  XBRL Presentations -- ndra-20221231_pre              XML    476K 
 9: EX-101.SCH  XBRL Schema -- ndra-20221231                         XSD    128K 
59: JSON        XBRL Instance as JSON Data -- MetaLinks              266±   356K 
60: ZIP         XBRL Zipped Folder -- 0001654954-23-003044-xbrl      Zip    253K 


‘EXCEL’   —   IDEA Workbook of Financial Reports


This is an IDEA Workbook.

        Download this Microsoft® Excel® .xlsx workbook


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/19/24  ENDRA Life Sciences Inc.          S-1                    9:1.1M                                   Blueprint/FA
 4/19/23  ENDRA Life Sciences Inc.          S-1/A                  1:357K                                   Blueprint/FA
 4/18/23  ENDRA Life Sciences Inc.          S-1/A                  5:515K                                   Blueprint/FA
 3/30/23  ENDRA Life Sciences Inc.          S-1                    6:959K                                   Blueprint/FA


22 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

12/19/22  ENDRA Life Sciences Inc.          8-K:1,9    12/16/22   13:515K                                   Blueprint/FA
12/08/22  ENDRA Life Sciences Inc.          8-K:5,9    12/08/22   13:159K                                   Blueprint/FA
 9/27/22  ENDRA Life Sciences Inc.          8-K:3,5,9   9/27/22   13:184K                                   Blueprint/FA
 3/30/22  ENDRA Life Sciences Inc.          10-K       12/31/21   65:5M                                     Blueprint/FA
 3/25/21  ENDRA Life Sciences Inc.          10-K       12/31/20   59:3.5M                                   Blueprint/FA
12/21/20  ENDRA Life Sciences Inc.          8-K:1,7,9  12/16/20    3:65K                                    Blueprint/FA
 8/14/20  ENDRA Life Sciences Inc.          10-Q        6/30/20   52:2.8M                                   Blueprint/FA
 1/15/20  ENDRA Life Sciences Inc.          8-K:1,7,9   1/13/20    3:76K                                    Blueprint/FA
12/27/19  ENDRA Life Sciences Inc.          8-K:5,9    12/27/19    3:57K                                    Blueprint/FA
12/26/19  ENDRA Life Sciences Inc.          8-K:1,3,5,912/19/19    4:390K                                   Blueprint/FA
12/11/19  ENDRA Life Sciences Inc.          8-K:1,3,7,912/05/19    6:503K                                   Blueprint/FA
 8/08/19  ENDRA Life Sciences Inc.          10-Q        6/30/19   49:2.1M                                   Blueprint/FA
 7/29/19  ENDRA Life Sciences Inc.          8-K:1,2,3,7 7/26/19    7:701K                                   Blueprint/FA
11/05/18  ENDRA Life Sciences Inc.          10-Q        9/30/18   47:2.2M                                   Blueprint/FA
 5/15/18  ENDRA Life Sciences Inc.          10-Q        3/31/18   44:1.7M                                   Blueprint/FA
 5/10/18  ENDRA Life Sciences Inc.          DEF 14A     6/12/18    1:985K                                   EdgarAgents LLC/FA
 3/20/18  ENDRA Life Sciences Inc.          10-K       12/31/17   54:3.2M                                   Blueprint/FA
 2/05/18  ENDRA Life Sciences Inc.          8-K:1,7,9   1/30/18    3:74K                                    Blueprint/FA
 5/12/17  ENDRA Life Sciences Inc.          8-K:5,9     5/08/17    6:209K                                   Blueprint/FA
 5/03/17  ENDRA Life Sciences Inc.          S-1/A                  6:721K                                   Blueprint/FA
12/06/16  ENDRA Life Sciences Inc.          S-1/A                 12:2.9M                                   Blueprint/FA
11/21/16  ENDRA Life Sciences Inc.          S-1        11/18/16   29:4.1M                                   Blueprint/FA
Top
Filing Submission 0001654954-23-003044   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 10, 12:50:47.3pm ET